Last updated: October 24, 2026. This article examines a manufacturer-supplied human-factors engineering report for FoldPumpVac FAC02-A and FAC02-B, revision 1.1 dated September 30, 2026, together with three on-site recordings of simulated use. It is written by Fitiger, which sells the product. The complete report, protocol, participant-level data and risk files are not public; the limited summary below should be read with that disclosure in mind. The videos are observational records, not emergency training, clinical outcomes or evidence of FDA authorization.
Imagine an adult caregiver opening a kit at a dining table while another person calls emergency services. The problem is not just whether a handle can move. The user must recognize the situation, avoid delaying established first aid, find the right components, understand the labeling, select a mask, use the device only within its intended population, and reassess rather than assuming that a visible motion solved the obstruction. That linked chain is why human-factors engineering matters. It examines the relationship among a person, an interface and the conditions of use. It is not a shortcut from “someone handled a training device” to “this device rescues people.” The FDA’s August 2026 human-factors guidance frames usability work around intended users, uses and use environments, with the goal of reducing harmful use error.
The report covers two FAC02 configurations. FAC02-A uses a spherical handle; FAC02-B uses a cylindrical handle. According to the manufacturer’s report, their function, dimensions and handling are otherwise the same, so FAC02-B was selected as the representative model for the reported formative and validation work. That rationale is useful, but it is not interchangeable with proof that every imaginable grip, instruction or environment behaves identically. A design-equivalence argument should always identify precisely which features differ, which user actions could be affected, and why one configuration can reasonably represent the other.
The completed evaluation summary identifies 30 participants: 15 lay rescuers and 15 healthcare professionals. That is the completed sample described by the report, not an earlier recruitment target and not a count of successful rescues. The report describes an adult operator aged at least 18 and excludes use on children under 1 year; readers should verify the current marketed labeling before acting. The public summary does not identify an individual in the videos as a layperson or clinician, and it does not provide a task-by-task result matrix. A viewer cannot infer success rates from the number of people in the report or the length of a clip. Nor can a simulated evaluation in 30 people estimate the probability of a real-world clinical outcome. The question supported by this material is narrower: how did intended users interact with the device and its instructions in a controlled simulated setting, and what kinds of use difficulties were considered?
The report organizes simulated activity around equipment preparation, mask selection and installation, device action, assessment, and after-use handling. Each stage creates a distinct chance for confusion. Preparation is not merely removing packaging: it asks whether the user can locate what is needed and tell one component from another. Mask selection asks whether the label and physical fit support the correct choice for the intended patient group. Connection asks whether the user can recognize a seated, ready assembly. Device action asks whether the interface communicates what to do without an instructor taking over. Assessment asks whether the user can recognize that the action is not the same thing as a resolved emergency. After-use handling raises different questions about the state of the kit and what must be replaced or checked before it is considered ready again.
Those questions are linked, but they should not be collapsed into a single “easy to use” verdict. A participant may work quickly yet miss a warning, or take a long pause for a good reason. An observer may see a hand on a mask but not see the user’s understanding of the age restriction. A participant may repeat an action because of uncertainty, because the scenario requires it, or because the camera starts in the middle of the sequence. The raw video cannot decide among those explanations without the protocol and observation notes. This is why a technical account should separate visible behavior from coded use issue, and both from any final risk evaluation.
In medical-device human factors, “critical task” refers to an action whose incorrect performance or omission could lead to serious harm. Whether any FAC02 step meets that formal threshold requires the manufacturer’s risk analysis and task definition, which are not disclosed here. We therefore describe the interaction stages, not a secret critical-task list or a pass/fail score. The FDA’s May 2026 guidance on human-factors information in marketing submissions describes a risk-based framework for documenting that information; a consumer-facing page with selected footage is not a substitute for a regulatory submission.
The first recording is about equipment preparation beside a small training manikin. It runs about 61 seconds. Viewers can see shifts of attention among packaging, the device, a mask and the model. That is enough to ask concrete questions about discoverability and sequencing. It is not enough to conclude that all setup tasks were completed correctly, that the participant had no prompts, or that the training model represents an approved patient age.
The second recording lasts about 145 seconds and shows handling around an adult training torso. A longer view can make pauses, repeated movements and transitions between components easier to notice. It also leaves more room for misreading: a smooth motion on an inert model is not suction performance in a living person, and a repeated movement is not automatically a mistake. A careful reviewer would ask what instructions the participant had, whether an observer intervened, what was visible outside the frame, and how the report coded the observation. Those questions matter more than producing a dramatic highlight reel.
The third recording lasts about 77 seconds and shows handling around a small training manikin. Here the age boundary needs to be unusually explicit. A small doll can make a video look like infant-use instruction even when the device’s own report excludes that population. The FAC02 report lists children under 1 year as a contraindication. The doll’s appearance does not change the labeling. The clip remains available because it is part of the authorized observation record, but it carries a persistent safety caption and a dedicated explanation rather than a promotional “how-to” label.
All three published clips preserve continuous motion at the original speed. We removed on-site audio, cropped for focus and placed a safety caption across each frame. These editorial changes do not turn the footage into a complete case record. A camera captures a bounded field of view; it cannot reveal the full protocol, the participant’s prior training, an off-screen prompt, a task score or the reason for a particular pause. The actual authorization to publish identifiable footage is held by the rights owner; the public page does not expose consent forms or participant records.
“Thirty people participated” is a denominator only if the numerator, task definition and observation conditions are also known. For example, a rate of “mask installation completed” would need a defined start and end state, what assistance counted as a prompt, how wrong-size selection was classified, whether a participant corrected an initial error, and whether both user groups faced the same task. The limited material released here does not disclose those values. Computing a percentage from screenshots, hand movements or the number of visible repetitions would manufacture precision that the public record does not support.
The same caution applies to the report’s conclusion that the final user interface was supported after observed use issues were assessed. That is the manufacturer’s human-factors conclusion under its study conditions. It is not independent proof of clinical effectiveness, a comparison against other devices or a regulator’s authorization decision. Technical readers should distinguish three levels of evidence: the report’s stated design and observations, a complete auditable HFE dataset, and clinical or real-world rescue evidence. This article exposes selected facts at the first level. It does not pretend to provide the second or third.
The report includes both lay and professional participants because the context and prior knowledge can differ. A healthcare professional may recognize airway terminology more quickly, while a family caregiver may rely heavily on visual labels and where the kit is stored. Yet professional status alone does not predict correct handling, and the visible clips do not identify who belonged to which group. A useful analysis asks whether instructions and physical cues remain understandable across realistic intended users without assuming that either group will behave perfectly.
Consider a shared household kit: an adult who bought it may know which bag contains the masks, while a visiting grandparent may see the device for the first time. A quick setup demonstration watched months earlier is not the same as finding the right part under stress. This scenario is an illustration of the human-factors problem, not a documented participant story from the report. It points to practical design questions—clear labels, visible age limits, intelligible mask identification and storage that does not hide the instructions—without inventing what the FAC02 participants said or did.
The FDA’s March 2026 safety communication says the public should follow established choking rescue protocols first; anti-choking devices may be considered as a second option if those standard steps do not work. The FDA also warns that unpacking and assembling a device can delay immediate established care. For a person with a complete airway obstruction, call local emergency services and follow current, age-appropriate training and dispatcher instructions. For a person who can still cough effectively, the response differs; do not treat every cough as a complete obstruction. This article is not a replacement for first-aid instruction.
The American Heart Association’s 2025 guideline update distinguishes adults and children from infants in its choking response. That distinction is not cosmetic: the actions appropriate for an infant differ, and FAC02’s reported under-one contraindication remains in force regardless of the doll used in a training film. No reader should copy a device-handling sequence from the small-manikin clips for an infant. Check the current FAC02 labeling for any other restrictions and use the emergency response taught by a recognized first-aid organization.
A second boundary is regulatory. A manufacturer-supplied HFE report, a product page and public video are not proof of FDA marketing authorization. FDA authorization, if relevant to a specific product and market, must be checked for that exact device in official databases; approval of another company’s anti-choking device would not transfer to FAC02. We make no such authorization claim here. We also do not present the videos as proof of a real rescue or an expected clinical success rate.
This checklist is deliberately more demanding than asking whether a clip “looks easy.” It can help caregivers, clinicians, institutional buyers and journalists ask better questions without turning incomplete evidence into a verdict. A qualified buyer should request the full, appropriate technical documentation through the relevant review channel if a purchasing or regulatory decision depends on details withheld from this public page.
Fitiger is disclosing the report revision/date, model relationship, representative-model rationale, completed participant groups, broad simulated task categories and three contextualized videos. We are not releasing the full protocol, individual identities beyond authorized footage, participant-level outcomes, detailed risk tables, exact numerical task results, confidential instructions or raw records. Holding those materials back should not be read as evidence of either a favorable or unfavorable result; it means this public article has a defined evidentiary ceiling. The full HFE dossier would be the place for an independent technical audit, not a marketing page.
For the model-specific public summary and all six videos across the two product families, visit Fitiger’s Human Factors & Usability overview. The three FAC02 recordings have separate explanatory pages for preparation, adult-manikin handling and small-manikin handling. For current product options and labeling, see the FoldPumpVac series and How It Works. For emergency-response training, start with recognized first-aid organizations and the current guidance in your jurisdiction, not a product video.
Sources and editorial disclosure. Primary study source: Shenzhen Huayu Wantuo Technology Co., Ltd., FAC02-A/FAC02-B Human Factors Engineering / Usability Engineering Report, revision 1.1, September 30, 2026 (manufacturer-supplied; full report not publicly posted). Public sources: FDA, Applying Human Factors and Usability Engineering to Medical Devices (August 2026); FDA, Content of Human Factors Information in Medical Device Marketing Submissions (May 2026); FDA, Choking Rescue Protocols safety communication (updated March 2026); AHA, 2025 CPR guideline update. Fitiger sells FoldPumpVac products. This article is a company-authored interpretation of selected manufacturer material, not independent peer review, medical advice or a clinical claim.
